T495-2866 Screening compound: N-{[5-(2-bromobenzenesulfonyl)-3-methyl-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridin-2-yl]methyl}propanamide

T495-2866 Screening compound: N-{[5-(2-bromobenzenesulfonyl)-3-methyl-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridin-2-yl]methyl}propanamide
T495-2866 Screening compound: N-{[5-(2-bromobenzenesulfonyl)-3-methyl-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridin-2-yl]methyl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T495-2866
N-{[5-(2-bromobenzenesulfonyl)-3-methyl-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridin-2-yl]methyl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T495-2866

Molecular Formula

C17H21BrN4O3S (C17 H21 BrN4 O3 S)

Compound Name

N-{[5-(2-bromobenzenesulfonyl)-3-methyl-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridin-2-yl]methyl}propanamide

IUPAC name

N-{[5-(2-bromobenzenesulfonyl)-3-methyl-3H4H5H6H7H-imidazo[45-c]pyridin-2-yl]methyl}propanamide

SMILES

CCC(NCc1nc(CCN(C2)S(c(cccc3)c3Br)(=O)=O)c2n1C)=O

InChI

InChI=1S/C17H21BrN4O3S/c1-3-17(23)19-10-16-20-13-8-9-22(11-14(13)21(16)2)26(24,25)15-7-5-4-6-12(15)18/h4-7H,3,8-11H2,1-2H3,(H,19,23)

InChI Key

YAIOBGRRQONGLK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27622034

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.35

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.649

Distribution Coefficient, logD

1.638

Water Solubility, LogSw

-2.44

Polar Surface Area

70.065

Acid Dissociation Constant (pKa)

13.29

Base Dissociation Constant (pKb)

5.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.20

T495-2866 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bromodomain Modulators Library (5801 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T495-2866 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T495-2866?
Check Price and Availability of T495-2866, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T495-2866 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T495-2866
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T495-2866
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T495-2866 available by request